In the TCGA-LUAD cohort, the results indicated that CYP4B1 mRNA expression was approximately 0.33-fold lower expressed in tumor tissues (n = 511) than in adjacent normal tissues (n = 59) (Fig 1A). The gene discussed is CYP4B1; the disease is neoplasm.